France’s Sanofi-Aventis Creating Joint Lab On Regenerative Medicine & Stem Cell Research With Beijing Hospital
This article was originally published in PharmAsia News
Executive Summary
BEIJING - To expand a matrix of partnerships with Chinese academic centers, the Paris-headquartered Sanofi-Aventis is launching a joint laboratory on regenerative medicine with the Xuanwu Hospital in the Chinese capital, according to Marc Cluzel, Sanofi's senior vice president for research and development
You may also be interested in...
China Emerging As World Power In Stem Cell Research
BEIJING - China is speedily evolving into a global power in terms of stem cell research, with the central government stepping up funding and recruiting scientists worldwide in order to catapult the country into the advance ranks of regenerative medicine, according to four scholars at the University of Toronto
China Emerging As World Power In Stem Cell Research
BEIJING - China is speedily evolving into a global power in terms of stem cell research, with the central government stepping up funding and recruiting scientists worldwide in order to catapult the country into the advance ranks of regenerative medicine, according to four scholars at the University of Toronto
France's Sanofi-Aventis Launches Research Outpost, Clinical Trial Workshops In Western China Region Torn By 2008 Earthquake
BEIJING - The Paris-headquartered Sanofi-Aventis is creating a small research base in the western Chinese province of Sichuan, the region that is still recovering after being hit by a magnitude 7.9 earthquake in mid-2008